XENETIC BIOSCIENCES, INC. Other Noncash Income (Expense)
XENETIC BIOSCIENCES, INC. (XBIO) reported Other Noncash Income (Expense) of $0 for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2017-11-14
- XENETIC BIOSCIENCES, INC. other noncash income (expense) for the quarter ending 2016-12-31 was -$40.61K.
- XENETIC BIOSCIENCES, INC. other noncash income (expense) for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- XENETIC BIOSCIENCES, INC. other noncash income (expense) for fiscal 2015 was $127.88K.
- XENETIC BIOSCIENCES, INC. other noncash income (expense) for fiscal 2014 was $0.00.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | ||
| 2016-12-31 | -$40.61K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $0.00 10-K · filed 2017-03-31 | |
| 2016-09-30 | $40.61K 10-Q · filed 2017-11-14 | ||
| 2015-12-31 | $127.88K 10-K · filed 2017-03-31 | ||
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |